Although the number of pediatric and adult drugs in short supply has dropped from an all-time high of 299 last year to 240 as of March 1, the lack of some medications continues to be a public health crisis.

“The situation may be improving a little bit here and there, but we haven’t seen a single defined solution for the problem yet, so we have to piecemeal solutions,” said Daniel A.C. Frattarelli, M.D., FAAP, chair of the AAP Committee on Drugs.

According to an investigation by the Drug Information Service into the reasons for the shortages last year, 44% were unknown, 36% were due to manufacturing issues, and the remaining 20% were because of supply and demand or discontinued drugs or raw materials.

“The good news is that we are not adding a lot of new drugs to what is already in short supply, but those that are in limited...

You do not currently have access to this content.